Muscle Pain Treatment



Fig. 3.1
KW test for strength and flexibility of key postural muscles; failure—inability to perform any of the tasks (Courtesy of the Norman Marcus Pain Institute)



In the absence of an electrical device to identify the muscular source of pain, manual palpation can sometimes correctly identify the muscle where the tenderness originates versus a referred muscle pain. To maximize the accuracy of the manual examination, an instrument that facilitates the application of a standard amount of pressure is suggested [135137].



Treatment Protocols


Patients who are diagnosed with muscle pain that does not lend itself to injection should receive treatment appropriate to the diagnosis. Therefore, patients who have stiffness, but not weakness, should not be given strengthening exercises since this will only further stiffen their muscles. The current nostrum (following the fads of low-impact aerobics [138140] and then closed-chain exercises [141, 142]) using core strengthening for back pain without any test of strength and flexibility is ill-founded [143].


Injection Technique


When muscle involvement is suggested and the evaluation protocol finds that injections are indicated, the authors suggest the use of the term Muscle Pain Amenable to Injection (MPAI), as opposed to “trigger point pain.” Suggested treatment consists of muscle-tendon injections (MTIs) instead of only TrP injections (TPIs), in order to include the regions (the entheses) with possibly the greatest density of sensitized nociceptors, followed by a structured physical therapy protocol which includes a validated set of exercises [144].

Patients should not be injected if they have a concurrent physical diagnosis (including morbid obesity, profound weakness and/or stiffness, Parkinson’s disease, severe peripheral neuropathy, or significant psychological comorbidities) that discourages aggressive treatment of the diagnosed muscle pain until the underlying problem is adequately addressed.

We suggest that only one muscle is injected during a given injection treatment. A needle that is long enough to reach the bony attachment of the muscle (between 25 gauge × 5/8 in. and 20 gauge × 3½ in.) is used, depending on the size and depth of the identified muscle. The treatment is the needle disrupting the muscle tissue with particular attention to the origin and insertion. NM refers to the injection as a muscle-tendon injection (MTI) because of the significant difference in location of the injections versus TPIs. An entire muscle, and not just a “point or taut band,” is injected.

The patient will typically first receive an intravenous analgesic. After seeing ketamine used for minor procedures at Walter Reed Army Medical Center, NM routinely uses it at a dose of <1 mg/kg, with total doses between 15 and 50 mg maximum, along with Midazolam 1–2 mg IV, with patients experiencing no pain from the procedure. Patients are counseled prior to the use of ketamine that they will have an unusual experience but that they will be able and are encouraged to keep discussing with me what they are feeling and thinking. Most patients elect to have ketamine on subsequent injections. The few that do not because of discomfort from the psychological effects of the ketamine, or lack of available recovery time, will be given a low-dose opioid, determined by the patient’s past response to opioids.

The area to be injected is swabbed with iodine. Next, up to 10 ml of 0.5 % lidocaine is injected into the subcutis overlying the indexed muscle (5 ml for muscles in the neck and above). After 5–8 min, the muscle is needled from its origin to its insertion point (including the muscle belly) with an additional 10 ml of 0.5 % lidocaine (5 ml for muscles in the neck and above) for comfort, down to the bony attachment. With such doses of lidocaine, NM has never produced a systemic lidocaine reaction.

To illustrate the treatment technique, consider the example of giving an MTI to the infraspinatus (see Figs. 3.1 and 3.2). After instilling subcutaneous lidocaine, the muscle is injected at the vertex of the scapula with a 22-gauge × 1½-in. needle, and with the needle still inserted, it is moved along the medial and lateral borders of the scapula, withdrawing and reinserting the needle as one proceeds up toward the spine of the scapula and the rotator cuff. Ice is applied for 4 min after the injection. The area is cleansed, and when all bleeding stops, the stable patient is released.

A329207_1_En_3_Fig2_HTML.gif


Fig. 3.2
The numbers represent the suggested sequence of muscle-tendon injections into the infraspinatus muscle down to the periosteum (With permission from the University of Washington)


Postinjection Physical Therapy


The MTI procedure causes some degree of pain both during and after the procedure. In order to facilitate additional injections and subsequent mobilization, the patient receives physical therapy on the day following the MTI. The physical therapy lasts for three consecutive days postinjection and consists of the patient receiving neuromuscular sine-wave stimulation (with ice) to a visible contraction, 2 seconds on and 2 seconds off, for a total of 15–20 min. This is followed by the first seven Kraus exercises for the lower body or the eight exercises for the upper body (see Figs. 3.3 and 3.4). Treatment always commences on a Monday to allow more than one muscle to be injected per week and to allow time for the three required post-MTI physical therapy sessions to be completed for each MTI. Therefore, treatment is considered complete on the final day of the post-MTI physical therapy session, of the last week that injections are given. Patients are given further instructions on the final day of physical therapy for the remaining 14 additional lower body exercises.

A329207_1_En_3_Fig3_HTML.gif


Fig. 3.3
Kraus-Marcus level 1 exercises for the relaxation and limbering of the lower body musculature (Courtesy of the Norman Marcus Pain Institute)


A329207_1_En_3_Fig4_HTML.gif


Fig. 3.4
Kraus upper quadrant exercises for flexibility of the neck and shoulder girdle (Courtesy of the Norman Marcus Pain Institute)


Summary of Suggestions for the Inclusion of Muscle Assessment in All Patients with Persistent Pain




1.

Any patients with persistent pain should undergo a thorough examination of all muscles that could possibly contribute to the pain complaint.

 

2.

Distinguish injectable muscle pain from pain related to tension, deficiency (weakness and/or stiffness), and spasm. We suggest the Kraus-Weber test for strength and flexibility of key postural muscles for low back and lower extremity pain. We suggest standard tests of upper body strength along with assessment of forward elevation and abduction of the arm and functional internal and external rotation of the shoulder (scapulohumeral and scapulothoracic motion) to find asymmetries of motion in the shoulder girdles which may suggest which muscle(s) may be involved.

 

3.

Attempt to identify primary versus referred muscle pain. (Identification through muscle stimulation appears to be more accurate than palpation.)

 

4.

Utilize a standardized exercise program to correct muscle deficiencies. We recommend the Kraus exercises: 8 for the upper body and 21 for the lower body.

 

5.

When injecting a specific muscle, pay particular attention to the entheses of the identified muscle rather than just TrPs and taut bands. Consider injecting only one muscle at a given injection session.

 

6.

If you use an injection procedure that targets the entire muscle, we recommend following up with 3 days of a postinjection physical therapy protocol to minimize postinjection soreness and stiffness.

 

7.

If more than one MPAI is identified and multiple treatments are planned, reassess the patient for continued presence of MPAI prior to injecting the next planned muscle. It is possible that changes may have taken place as a result of successful injection. These changes may be related to central sensitization (the next muscle is no longer painful to manual or electrical stimulation) or CPM (a new muscle is painful after the previous; most severely painful muscle was successfully treated).

 

In future editions of this textbook, we hope to be able to publish head-to-head comparisons of other proposed and published comprehensive protocols.


Unusual Clinical Presentations in Which Muscles Played a Role


The following extraordinary case examples are presented not as a suggestion that all patients with the initial putative diagnoses below have muscle pain, but rather that we do not know whether any of our patients with persistent pain complaints have an overlooked, treatable muscle pain because we are not routinely and systematically looking at their muscles as a possible source of pain. Ignoring muscles in patients with chronic pain may lead to unnecessary treatment failures and, in some cases, exacerbation rather than elimination of the pain complaint.


Complex Regional Pain Syndrome (CRPS)


A 50-year-old woman suffered a right-sided tibia/fibula fracture requiring open reduction and internal fixation and postoperatively developed complex regional pain syndrome in her foot and lower leg with discoloration, swelling, restricted range of motion, allodynia, and decreased temperature. Her initial diagnosis was made at a prominent New York City hospital. She received ketamine infusions, spinal cord stimulation, and a variety of traditional medications utilized for CRPS. She was unable to wear a sock or a closed-toe shoe. She was severely depressed. She was seen for assessment five and a half years after the onset of her symptoms. Examination revealed pain emanating from the bilateral quadratus lumborum, left piriformis, left peroneus, left tibialis posterior, left soleus, left extensor hallucis longus, and left extensor digitorum longus muscles. The muscles were treated in the fashion previously described. She was pain free for approximately 4 months after her last treatment, with no restrictions and no medication, wearing a normal shoe and playing golf.

Her pain then returned, coincident with failed rotator cuff surgery and cessation of her prescribed lower body exercises, as well as the onset of wintry weather. Interestingly, only the dysesthetic pain and allodynia at the surgical scar site returned and not the skin color, temperature, and sweat changes. She was found to have MPAI in the following muscles: right quadratus lumborum (pain reduced 50 % after injection), piriformis (pain reduced 30 % after injection), extensor digitorum longus (pain reduced 10 % after injection), and extensor hallucis longus (complete relief of pain after injection). At the time of this writing, the patient has been essentially pain free for more than two years.


Failed Back Surgery Syndrome (FBSS)/Spinal Stenosis


A 65-year-old entrepreneur with a 15-year history of back and leg pain was diagnosed with spinal stenosis and underwent two failed lumbar spine fusions at a prominent surgically oriented hospital. He was told that his only option for his persistent pain, which prevented him from leaving his home and socializing with friends and family, was a spinal cord stimulator or an epidural morphine pump. He was on round-the-clock opioid analgesia. In November 2005, he was evaluated for the presence of muscles as a source of his now persistent bilateral anterior thigh pain. Three muscles were identified—the right gluteus maximus and the left tensor fascia lata and vastus lateralis—and injected. One month after, he was essentially pain free and ambulating normally and remains pain free 5 years after his last injection. He has been able to travel to Vietnam and China and reports no impairments secondary to back or proximal leg pain.

FBSS is generally considered to be only amenable to palliative interventions such as spinal cord stimulation and/or lifelong delivery of potent analgesics, orally or parenterally. We have previously reported on a series of patients with FBSS successfully treated for muscle pain in the same fashion [145].


Fibromyalgia/Disk Protrusion


A 42-year-old woman with a 2-year history of neck, head, back, and lower extremity pain following an auto accident (causing her to spend days and weeks in bed with severe pain) was evaluated by multiple physicians and diagnosed with fibromyalgia. It was suggested that she undergoes cervical/lumbar spinal fusion as well. She was evaluated for the presence of muscle pain, and 13 muscles were identified—in the upper body, bilateral frontalis, infraspinatus, pectoralis minor, and left anterior/medial scalenes; and in the lower body, bilateral quadratus lumborum, gluteus medius, and right gluteus maximus, and piriformis. Since the most intense and disabling pain was in her head and neck, this region was treated first. After five muscles had been injected in her upper body (bilateral infraspinatus, frontalis, and left pectoralis minor), she reported that nearly all of the upper and lower body pain was eliminated. No other muscle injections needed to be done. She is now without any pain-related impairment, 1 year after her last treatment.

Patients with imaging studies suggesting clinically meaningful spinal pathology may also present with diffuse pain diagnosed as FMS. Spinal fusion may be suggested. Some of these patients may have treatable muscle pain.


Rotator Cuff Tear


A 60-year-old medical assistant with a 2-year history of severe right shoulder pain and markedly restricted of range of motion was found to have a full-thickness buttonhole tear of the supraspinatus tendon on MRI. He was scheduled for rotator cuff surgery repair but was evaluated prior to surgery for muscle-based pain and found to have tenderness in six muscles of his shoulder girdle—coracobrachialis, trapezius, levator scapula, posterior para-cervicals, biceps brachii, and pectoralis major—which were successfully injected with elimination of all pain and total restoration of his range of motion (and subsequent cancellation of his surgery). He remained without pain or restriction for the 1 year he was followed.

Shoulder pain is inconsistently evaluated and treated [146148]. Including the routine examination for specific shoulder muscle pain and dysfunction could decrease unnecessary surgeries and long-term use of analgesics.


Future Directions


The addition of a muscle protocol into the standard pain treatment paradigm should be supported by adequate RCTs to establish the validity of any intervention. In the realm of injection techniques to treat NSCLB, such a formidable task has uniquely been done by Francisco Kovacs.


Neuroreflexotherapy (NRT)


Neuroreflexotherapy (NRT) consists of the temporary implantation of a number of epidermal devices (surgical staples and small “burins” implanted subcutaneously) in trigger points in the back at the site of dermatomes and at the referred tender points located in the ear. The purpose is to “deactivate” neurons assumed to be involved in the persistence of pain, neurogenic inflammation, muscle dysfunction, and contracture.

As recognized by the Cochrane Back Review Group, NRT is one of the few technologies which has shown to be effective through high-quality, randomized, controlled trials and to provide “unusually positive” results [149]. This technology is currently implemented in Spain through the Spanish National Health System [150], and its evaluation in other countries is warranted.


Fascial Pain


Muscles do not function in a vacuum, and the relationship of muscle to its adjacent fascia and ligaments has not been systematically explored. As obscure as the data on muscle pain may be, fascial pain is even more so. The dynamic structure and function of fascia has not been appreciated. Fascia appears to have contractile properties that make it integral to efficient muscle contraction [151], as well as mechanosensitive properties which provide important information to surrounding muscles. Fascia has been shown to refer pain to different structures [152]. Therefore, damaged fascia may play an important role in chronic and recurrent low back pain [153, 154].

Stretching of injured muscle and tendon appears to inhibit scarring, which may be related to the production of transforming growth factor (TGF) beta 1 by damaged fascia [155]. In surgical procedures where fascia is resected, one should at least consider preservation of functional integrity whenever possible.


Regional Nonspecific Neck Pain


Regional pain such as neck pain is loosely defined [156], and although muscles are acknowledged as one of the pain-producing structures, little data exist on their importance. Andersen et al. [157] demonstrated that when pain was predominantly from the trapezius muscle (i.e., trapezius myalgia), strength training of the trapezius and surrounding muscles resulted in large decreases in pain that were sustained months after cessation of the study. Vuillerme and Pinsault [158] demonstrated the importance of intact nonpainful neck muscles in maintaining normal balance. In using manual palpation to identify muscle-related neck pain, facet arthropathy may be confused with pain associated with muscle attachments on the cervical spine [159]. Multifaceted treatment remains the norm for generic neck pain. In a systematic review, Chow found low-level laser therapy (LLLT) to be effective for acute- and moderate-duration neck pain [160], although a recent Cochrane review found that LLLT appeared to be ineffective [161].


Summary


Muscle and other soft tissue may be a primary source of common pain complaints and, if consistently acknowledged in our evaluation and treatment protocols, could result in improved treatment outcomes.


References



1.

Wall PD, Woolf CJ. Muscle but not cutaneous C-afferent input produces prolonged increases in the excitability of the flexion reflex in the rat. J Physiol. 1984;356:443–58.PubMedCentralPubMed


2.

Fishman SM, Ballantyne JC, Rathmell JP, editors. Bonica’s management of pain. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2009.


3.

McMahon SB, Koltzenburg M, editors. Wall and Melzack’s textbook of pain. 5th ed. Philadelphia: Elsevier/Churchill Livingstone; 2005.


4.

Aronoff GM. Evaluation and treatment of chronic pain. 3rd ed. Baltimore: Lippincott Williams & Wilkins; 1999.


5.

Benzon H, Rathmell J, Wu C, Turk D, Argoff C, editors. Raj’s practical management of pain. 4th ed. St. Louis: Mosby; 2008.


6.

Wallace DJ. The history of fibromyalgia. In: Wallace DJ, Clauw DJ, editors. Fibromyalgia and other central pain syndromes. 1st ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 1–5.


7.

Reynolds MD. The development of the concept of fibrositis. J Hist Med Allied Sci. 1983;38(1):5–35.PubMed


8.

Inanici F, Yunus MB. History of fibromyalgia: past to present. Curr Pain Headache Rep. 2004;8:369–78.PubMed


9.

Cohen M, Quintner J. The horse is dead: let myofascial pain syndrome rest in peace [letter]. Pain Med. 2008;9(4):464–5.PubMed


10.

Marcus N. Response to letter to the editor by Dr. Cohen and Dr. Quintner [letter]. Pain Med. 2008;9(4):466–8.PubMed


11.

Kellgren JH. Observations on referred pain arising from muscle. Clin Sci. 1938;3:174–90.


12.

Kellgren JH. On distribution of pain arising from deep somatic structures with charts of segmental pain areas. Clin Sci. 1939;4:35–6.


13.

Lewis T, Kellgren JH. Observations relating to referred pain, visceromotor reflexes and other associated phenomena. Clin Sci. 1939;4:47–71.


14.

Mense S, Hoheisel U. Central hyperexcitability and muscle nociception. In: Graven-Nielsen T, Arendt-Nielsen L, Mense S, editors. Fundamentals of musculoskeletal pain. 1st ed. Seattle: IASP; 2008. p. 61–73.


15.

Arendt-Nielsen L, Graven-Nielsen T. Translational aspects of musculoskeletal pain. In: Graven-Nielsen T, Arendt-Nielsen L, Mense S, editors. Fundamentals of musculoskeletal pain. 1st ed. Seattle: IASP; 2008. p. 347–66.


16.

Schade H. Untersuchungen in der Erkaltungsfrage. III: Ueber den rheumatismus, insbesondere den muskelrheumatismus (myogelose). Munch Med Wschr. 1921;68:418–20.


17.

Lange M. Die Muskelhärten (Myogelosen): Ihre Entstehung und Heilung. Munich: Lehmann; 1931.


18.

Steindler A. The interpretation of sciatic radiation and the syndrome of low-back pain. J Bone Joint Surg Am. 1940;22:28–34.


19.

Travell JG, Rinzler SH, Herman M. Pain and disability of the shoulder and arm: treatment by intramuscular infiltration with procaine hydrochloride. JAMA. 1942;120:417–22.


20.

Travell JG, Rinzler SH. The myofascial genesis of pain. Postgrad Med. 1952;11:425–34.PubMed


21.

Simons DG, Travell JG. Myofascial origins of low back pain. 1. Principles of diagnosis and treatment. Postgrad Med. 1983;73(2):66–73.PubMed


22.

Reeves R. President Kennedy: profile of power. New York: Simon and Schuster; 1993. p. 15, 82–85, 120, 242–3.


23.

Smythe H. Tender points: the evolution of concepts of the fibrositis/fibromyalgia syndrome. Am J Med. 1986;81(3A):2–6.PubMed


24.

Moldofsky H, Scarisbrick P, England R, Smythe H. Musculoskeletal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects. Psychosom Med. 1975;37:341–51.PubMed

Oct 21, 2016 | Posted by in PAIN MEDICINE | Comments Off on Muscle Pain Treatment

Full access? Get Clinical Tree

Get Clinical Tree app for offline access